These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
116 related items for PubMed ID: 17974960
1. Cell growth inhibition by okadaic acid involves gut-enriched Kruppel-like factor mediated enhanced expression of c-Myc. Zhang L, Wali A, Ramana CV, Rishi AK. Cancer Res; 2007 Nov 01; 67(21):10198-206. PubMed ID: 17974960 [Abstract] [Full Text] [Related]
2. Okadaic acid-mediated induction of the c-fos gene in estrogen receptor-negative human breast carcinoma cells utilized, in part, posttranscriptional mechanisms involving adenosine-uridine-rich elements. Farhana L, Boyanapalli M, Tschang SH, Sun RJ, Hsu CK, Zhang YX, Fontana JA, Rishi AK. Cell Growth Differ; 2000 Oct 01; 11(10):541-50. PubMed ID: 11063127 [Abstract] [Full Text] [Related]
3. c-Myc creates an activation loop by transcriptionally repressing its own functional inhibitor, hMad4, in young fibroblasts, a loop lost in replicatively senescent fibroblasts. Marcotte R, Chen JM, Huard S, Wang E. J Cell Biochem; 2005 Dec 01; 96(5):1071-85. PubMed ID: 16167342 [Abstract] [Full Text] [Related]
4. Growth factor-dependent regulation of survivin by c-myc in human breast cancer. Cosgrave N, Hill AD, Young LS. J Mol Endocrinol; 2006 Dec 01; 37(3):377-90. PubMed ID: 17170079 [Abstract] [Full Text] [Related]
5. Myc represses differentiation-induced p21CIP1 expression via Miz-1-dependent interaction with the p21 core promoter. Wu S, Cetinkaya C, Munoz-Alonso MJ, von der Lehr N, Bahram F, Beuger V, Eilers M, Leon J, Larsson LG. Oncogene; 2003 Jan 23; 22(3):351-60. PubMed ID: 12545156 [Abstract] [Full Text] [Related]
6. Differential expression of genes associated with cell proliferation and apoptosis induced by okadaic acid during the transformation process of BALB/c 3T3 cells. Ao L, Liu JY, Gao LH, Liu SX, Yang MS, Huang MH, Cao J. Toxicol In Vitro; 2008 Feb 23; 22(1):116-27. PubMed ID: 17935941 [Abstract] [Full Text] [Related]
7. Cell growth suppression by thanatos-associated protein 11(THAP11) is mediated by transcriptional downregulation of c-Myc. Zhu CY, Li CY, Li Y, Zhan YQ, Li YH, Xu CW, Xu WX, Sun HB, Yang XM. Cell Death Differ; 2009 Mar 23; 16(3):395-405. PubMed ID: 19008924 [Abstract] [Full Text] [Related]
8. Growth inhibition and apoptosis induced by daunomycin-conjugated triplex-forming oligonucleotides targeting the c-myc gene in prostate cancer cells. Napoli S, Negri U, Arcamone F, Capobianco ML, Carbone GM, Catapano CV. Nucleic Acids Res; 2006 Mar 23; 34(2):734-44. PubMed ID: 16449206 [Abstract] [Full Text] [Related]
9. Krüppel-like factor 5 promotes breast cell proliferation partially through upregulating the transcription of fibroblast growth factor binding protein 1. Zheng HQ, Zhou Z, Huang J, Chaudhury L, Dong JT, Chen C. Oncogene; 2009 Oct 22; 28(42):3702-13. PubMed ID: 19668233 [Abstract] [Full Text] [Related]
10. A nucleus-localization-deficient mutant serves as a dominant-negative inhibitor of gut-enriched Krüppel-like factor function. Shie JL, Tseng CC. Biochem Biophys Res Commun; 2001 Apr 27; 283(1):205-8. PubMed ID: 11322789 [Abstract] [Full Text] [Related]
11. Induction of p53 by GKLF is essential for inhibition of proliferation of vascular smooth muscle cells. Wassmann S, Wassmann K, Jung A, Velten M, Knuefermann P, Petoumenos V, Becher U, Werner C, Mueller C, Nickenig G. J Mol Cell Cardiol; 2007 Sep 27; 43(3):301-7. PubMed ID: 17659301 [Abstract] [Full Text] [Related]
12. Adenovirus E1A oncoprotein liberates c-Myc activity to promote cell proliferation through abating Bin1 expression via an Rb/E2F1-dependent mechanism. Kinney EL, Tanida S, Rodrigue AA, Johnson JK, Tompkins VS, Sakamuro D. J Cell Physiol; 2008 Sep 27; 216(3):621-31. PubMed ID: 18348166 [Abstract] [Full Text] [Related]
13. Transcriptional repression of WEE1 by Kruppel-like factor 2 is involved in DNA damage-induced apoptosis. Wang F, Zhu Y, Huang Y, McAvoy S, Johnson WB, Cheung TH, Chung TK, Lo KW, Yim SF, Yu MM, Ngan HY, Wong YF, Smith DI. Oncogene; 2005 Jun 02; 24(24):3875-85. PubMed ID: 15735666 [Abstract] [Full Text] [Related]
14. JAK pathway induction of c-Myc critical to IL-5 stimulation of cell proliferation and inhibition of apoptosis. Lee WH, Liu FH, Lin JY, Huang SY, Lin H, Liao WJ, Huang HM. J Cell Biochem; 2009 Apr 01; 106(5):929-36. PubMed ID: 19180571 [Abstract] [Full Text] [Related]
16. De-repression of the p21 promoter in prostate cancer cells by an isothiocyanate via inhibition of HDACs and c-Myc. Wang LG, Liu XM, Fang Y, Dai W, Chiao FB, Puccio GM, Feng J, Liu D, Chiao JW. Int J Oncol; 2008 Aug 01; 33(2):375-80. PubMed ID: 18636159 [Abstract] [Full Text] [Related]
17. c-Myc inhibits Ras-mediated differentiation of pheochromocytoma cells by blocking c-Jun up-regulation. Vaqué JP, Fernández-García B, García-Sanz P, Ferrandiz N, Bretones G, Calvo F, Crespo P, Marín MC, León J. Mol Cancer Res; 2008 Feb 01; 6(2):325-39. PubMed ID: 18314492 [Abstract] [Full Text] [Related]
18. A novel factor distinct from E2F mediates C-MYC promoter activation through its E2F element during exit from quiescence. Alvaro-Blanco J, Martínez-Gac L, Calonge E, Rodríguez-Martínez M, Molina-Privado I, Redondo JM, Alcamí J, Flemington EK, Campanero MR. Carcinogenesis; 2009 Mar 01; 30(3):440-8. PubMed ID: 19126644 [Abstract] [Full Text] [Related]
19. Transcriptional regulation of A33 antigen expression by gut-enriched Krüppel-like factor. Mao Z, Song S, Zhu Y, Yi X, Zhang H, Shang Y, Tong T. Oncogene; 2003 Jul 10; 22(28):4434-43. PubMed ID: 12853980 [Abstract] [Full Text] [Related]
20. The c-myc promoter: still MysterY and challenge. Wierstra I, Alves J. Adv Cancer Res; 2008 Jul 10; 99():113-333. PubMed ID: 18037408 [Abstract] [Full Text] [Related] Page: [Next] [New Search]